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Background: Ivermectin (IVM) silences activity in neurons expressing glutamate-gated chloride channels (GluCl).
Results: Rational point mutations in GluCl robustly increase IVM-induced conductance and reduce the variability of spike
suppression in cultured neurons.
Conclusion: The newly engineered receptor improves heteromeric receptor expression and sensitivity to IVM.
Significance: GluClv2.0 is an improved tool for IVM-induced silencing.
Amodified invertebrate glutamate-gated Cl channel (GluCl
) was previously employed to allow pharmacologically
induced silencing of electrical activity in CNS neurons upon
exposure to the anthelmintic drug ivermectin (IVM).Usefulness
of theprevious receptorwas limitedby1) thehigh concentration
of IVMnecessary to elicit a consistent silencing phenotype, rais-
ing concern about potential side effects, and 2) the variable
extent of neuronal spike suppression, due to variations in the
co-expression levels of the fluorescent protein-tagged  and 
subunits. To address these issues, mutant receptors generated
via rational protein engineering strategies were examined for
improvement. Introduction of a gain-of-function mutation
(L9F) in the second transmembrane domain of the  subunit
appears to facilitate  subunit incorporation and substantially
increase heteromeric GluCl  sensitivity to IVM. Removal of
an arginine-based endoplasmic reticulum retention motif (RSR
mutated to AAA) from the intracellular loop of the  subunit
further promotes heteromeric expression at the plasma mem-
brane possibly by preventing endoplasmic reticulum-associated
degradation of the  subunit rather than simply reducing endo-
plasmic reticulum retention. A monomeric XFP (mXFP) muta-
tion that prevents fluorescent protein dimerization comple-
ments the mutant channel effects. Expression of the newly
engineered GluCl opt -mXFP L9F  opt -mXFP Y182F
RSR_AAA receptor in dissociated neuronal cultures markedly
increases conductance and reduces variability in spike suppres-
sion at 1 nM IVM. This receptor, named “GluClv2.0,” is an
improved tool for IVM-induced silencing.
The development of optogenetic and orthogonal pharmaco-
genetic techniques tomanipulate neuronal activity has become
an important sector of neuroscience. These tools enable map-
ping of neuronal connectivity and are essential for assigning
functional roles to particular cell types and determining their
contribution to perception or behavior. We previously used a
heteromeric glutamate-gated chloride channel (GluCl )
cloned from the invertebrate species Caenorhabditis elegans to
silence mammalian neuronal activity in vivo (1). Activation of
GluCl channels by the anthelmintic drug ivermectin (IVM)2
elicits a chloride conductance that drives themembrane poten-
tial toward the Nernst potential of Cl (ECl), preventing action
potential generation for effective neuronal silencing (2).
Prior to its implementation as a silencing tool, the C. elegans
GluCl receptor underwent several genetic modifications. First,
it was rendered insensitive to its native ligand glutamate by a
single point mutation (Y182F) in the  subunit (3). Second, the
DNA sequences of the invertebrate  and  subunits were
codon-optimized (opt  and opt ) to achieve greater protein
expression levels in mammalian cells (4). Third, fluorescent
protein tags (YFP and CFP; often noted as XFP) were inserted
into the large intracellular loop of each subunit to allow for
direct visualization of protein expression (3). We refer to this
GluCl opt -XFP opt -XFP Y182F receptor throughout this
paper as “GluCl version 1.0” or simply “GluClv1.0.”
The GluCl/IVM method was the first to show neuronal
silencing induced by a systemically administered drug in awake,
behaving animals (1). IVM administration caused unidirec-
tional rotational behavior in mice expressing GluClv1.0 in the
unilateral striatum, indicating that striatal neurons were
silenced. The rotational behavior was observed within hours of
induction and was fully reversed within days, allowing multiple
cycles of silencing and recovery to be performed on a single
animal. Selective and reversible silencing was achieved without
measurable toxicity to either individual neurons or the animal
as a whole. However, the dose of IVM required to elicit a con-
sistent silencing phenotype (5–10 mg/kg) (1) was higher than
that routinely used to treat mice with parasitic infections (0.2
mg/kg) (5), presumably because engineered silencing requires
CNS penetration. The required concentrations were in the
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range to raise concern about potential side effects because IVM
is known to activate (or potentiate) other ligand-gated ion
channels in the CNS, although it does so much less potently
than GluCl (6–9). In addition, the silencing phenotype dis-
played a bimodal distribution that correlated with both the
extent of viral infection (i.e. the volume of striatum expressing
GluCl ) and the extent of spike suppression (i.e. individual
neurons showing either full, partial, or no inhibition), which
further correlated with the co-expression levels of  and 
subunits.
GluClv1.0 was thus a candidate for rational protein optimi-
zation that would 1) alleviate the concern of off-target side
effects and 2) avoid suboptimal spike inhibition. Toward aim 1,
we screened heteromeric GluCl  for increased sensitivity to
IVM by introducing channel gating mutations in the second
transmembrane domain of the  subunit. To employ IVM
effectively as an orthogonal silencing tool, however, we had to
reinstate glutamate insensitivity (by reintroduction of the
Y182F mutation) to this hypersensitive mutant receptor. For
aim 2, we suspected that inadequate surface expression of the 
subunit was responsible for the variability in spike suppression.
To improve heteromeric receptor expression at the plasma
membrane, putative trafficking determinants of the  subunit
were mutated. An additional mutation designed to prevent
fluorescent protein dimerization appeared to enhance hetero-
meric subunit assembly. Altogether, in vitro silencing experi-
ments unequivocally show that the resultingmutant receptor is
a more sensitive and less variable GluCl/IVM silencing tool.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis—Codon optimized sequences of
the C. elegans GluCl channel, including optGluCl WT,
optGluCl WT, optGluCl -XFP, and optGluCl -XFP (4),
cloned into plasmid vector pcDNA3.1/V5-His TOPO (catalog
no. K4800-01, Invitrogen) were used in this study. Fluorescent
protein insertions (XFP) include enhanced yellow (YFP) and
cyan (CFP) variants and are located in theM3-M4 loop (3). For
convenience, the “opt” nomenclature is omitted throughout
most of this paper. Mutations were made using the
QuikChange II XL site-directed mutagenesis kit (catalog no.
200522, Agilent Technologies) and PfuTurboDNApolymerase
(catalog no. 600250, Agilent Technologies). Forward and
reverse primers for the ()L9F mutation were 5-CC CTG
GGC GTG ACC ACC CTG xxx AC-3 and 5-GC GGA CTG
AGC GGT CAT GGT xxx CA-3, where “xxx” delineates the
mutated Leu9 codon. Leu9 mutations included Ile, Phe, Val,
Ser, Thr, Ala, and Gly. Additional mutations in this study were
generated using the following forward and reverse primers
(mutant codon is italicized in the forward primer): 5-AC TTC
GAC CTG GTG TCC TTC GCC CAC ACC-3 and 5-GGT
GTG GGC GAA GGA CAC CAG GTC GAA GT-3 for the
()Y182F mutation; 5-TAC CTG AGC TAC CAG TCC AAG
CTG AGC AAA GAC CCC AAC-3 and 5-GTT GGG GTC
TTT GCT CAG CTT GGA CTG GTA GCT CAG GTA-3 for
the monomeric YFP A206K mutation; 5-TG CGC CAG AAC
GAC GCC GCC GCC GAG AAG GCG GCC C-3 and 5-G
GGC CGC CTT CTC GGC GGC GGC GTC GTT CTG GCG
CA-3 for the ()RSR_AAA mutation; 5-CG GCC CGC AAG
GCC CAG GCA GCC GCC GAG AAG CTG GAG ATG G-3
and 5-C CAT CTC CAG CTT CTC GGC GGC TGC CTG
GGCCTTGCGGGCCG-3 for the ()RRR_AAAmutation. A
C-terminal V5 tag was added to  and  subunits by mutating
the stop codon using the following primers: 5-G CAG AAC
GTT CTG TTC GGAGCT AGC AAG GGC AA-3 and 5-TT
GCCCTTGCTAGCTCCGAACAGAACGTTCTGC-3 for
the  subunit; 5-CC GAG TCC CTG GTG TTG GCT AGC
AAG G-3 and 5-C CTT GCT AGC CAA CAC CAG GGA
CTC GG-3 for the  subunit. All mutations were verified by
DNA sequencing.
Cell Culture—Human embryonic kidney 293 (HEK293) cells
were purchased fromATCC (catalog no. CRL-1573). Cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM; cat-
alog no. 11965, Invitrogen) supplemented with 10% FBS (cata-
log no. 26140, Invitrogen), 100 units/ml penicillin, 100 g/ml
streptomycin (catalog no. 15140, Invitrogen), and 1mM sodium
pyruvate (catalog no. 11360, Invitrogen) and maintained at
37 °C and 5% CO2 in a humidified incubator. Cells were pas-
saged when confluent at a subcultivation ratio of 1:5 or 1:10
every 3–4 days. For FlexStation assays, HEK293 cells were
plated at 20,000 cells/well, with a plating volume of 100l/well,
in a black-sided/clear-bottomed 96-well imaging plate (catalog
no. 353219, BD Falcon). For transfection, 16g of total DNA in
750l of DMEMwasmixed with 30l of ExpressFect in 750l
DMEM, preincubated for 20 min, and then added at 15 l/well
to cells containing 100 l of fresh culture medium. Transfec-
tion mixes were removed from cultures following a 4–6-h
incubation period at 37 °C/5%CO2 and replacedwith fresh cul-
ture medium. For total internal reflection fluorescence (TIRF)
imaging, HEK293 cells were plated on 35-mm glass bottom
culture dishes (catalog no. P35G-1.5-10-C, MatTEK) at 50,000
cells/dish. Cells were transfected with 1g of DNA in 100l of
DMEM plus 4 l of ExpressFect (catalog no. E2650, Denville
Scientific) in 100l of DMEMthatwas preincubated for 20min
before adding to culture dishes containing 2 ml of fresh culture
medium. The transfection mix was removed after 4–6 h and
replaced with fresh culture medium. For all experiments,
HEK293 cells were transfected 24 h after plating and assayed
48 h after transfection.
Hippocampal neurons were obtained from day 18Wistar rat
embryos (10) and plated at a density of 40,000 cells/dish on
35-mm glass bottom culture dishes coated with poly-DL-lysine
(catalog no. P9011, Sigma). Neurons were cultured in Neuro-
basal medium (catalog no. 21103-049, Invitrogen) containing
2% B27 (catalog no. 17504-044, Invitrogen) and 0.5 mM Glu-
tamax (catalog no. 35050, Invitrogen). Medium was supple-
mented with 5% equine serum (catalog no. SH30074, Hyclone)
during plating. Cultures were maintained at 37 °C and 5% CO2
in a humidified incubator with a 50% medium exchange once
per week. For imaging experiments, neurons were treated with
1 M cytosine arabinoside (catalog no. C1768, Sigma) on cul-
ture day 10, followed by a 100% medium change the next day.
Cultures used for electrophysiological experiments were not
treated with cytosine arabinoside. Neurons were transiently
transfected after 13–14 days in culture and assayed 24 h later.
Transfections were prepared using 4 g of plasmid DNA with
20 g of Nupherin-neuron (catalog no. SE-225, BIOMOL) and
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10 l of Lipofectamine 2000 (catalog no. 11668-019, Invitro-
gen) diluted separately in 400 l of Neurobasal without phenol
red (catalog no. 12348-017, Invitrogen). The diluted reagents
were preincubated separately at room temperature for 15 min
and then combined and incubated for another 45 min. An
800-l volume of conditionedmediumwas then removed from
the neuronal culture dish and replaced with the 800-l trans-
fection mix. After incubating cultures for 1 h at 37 °C/5% CO2,
an 800-l volumewas removed from the dish and replacedwith
the original 800 l of conditioned medium.
Fluorescent Membrane Potential Measurements—Fluores-
cent membrane potential assays were performed using the
FlexStation 3 multimode benchtop microplate reader and the
BLUE formulation kit (catalog no. R8042, Molecular Devices).
Dye loading buffer was prepared according to the instructions
of themanufacturer. To perform the assay, culturemediumwas
removed from the cells and replacedwith 50l of DMEM.Cells
were then loaded with 50 l of blue dye loading buffer and
incubated for 40min at 37 °C/5%CO2. Fluorescence wasmeas-
ured at ambient temperature using the “Low PMT” setting of
the FlexStation 3 operated by SoftMax Pro Data Acquisition
and Analysis Software. Excitation and emission wavelengths
were set at 530 and 565 nm, respectively. The emission cut-off
was 550 nm. Other FlexStation parameters included a pipette
dispensing height of 230 l for a 300-l volume well, an initial
well volume of 100 l, a transfer volume of 50 l (therefore,
drug concentrations were prepared three times), and a transfer
rate setting of 2, corresponding to 31 l/s. Ivermectin con-
centrations for the FlexStation assay were prepared as 1:10
serial dilutions of 10, 5, and 2 M using a 1 commercial stock
of Hanks’ balanced salt solution (without phenol red; catalog
no. 14025, Invitrogen) with 20 mM HEPES, pH 7.4, containing
0.1% DMSO.
Electrophysiology—We used an Axopatch 200A amplifier
equipped with a CV201 headstage and Digidata 1200 series
interface operated by Clampex version 9.2 software (Axon
Instruments) to obtain electrophysiological recordings from
neurons in whole-cell current clamp mode. Stepwise square
current pulses (100 to 250 pA, 25-pA increments) were used
to generate action potentials. Data were sampled at 50 kHz and
low pass-filtered at 5 kHz. Neurons were superfused (or incu-
bated) with artificial cerebrospinal fluid composed of 110 mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 10 mM D-glu-
cose, 10 mM HEPES, pH 7.4, 230 mosM. Patch pipettes were
pulled from borosilicate glass and had resistances of 7–12
megaohms when filled with the internal solution (100 mM
potassium gluconate, 0.1 mM CaCl2, 5 mM MgCl2, 1.1 mM
EGTA, 10 mM HEPES, 3 mM Mg-ATP, 0.3 mM GTP,
3mMphosphocreatine, pH7.2, 215mosM. IVMwas dissolved in
artificial cerebrospinal fluid containing 0.1% DMSO and prein-
cubated with cultures at 37 °C/5% CO2 for 15 min. All record-
ings were obtained at ambient temperature.
Data were analyzed using Clampfit version 9.2 software.
Resting membrane potential was measured in the absence of
injected current and corrected for the liquid junction potential
at the electrode tip. Tominimize the confounding effects of seal
rupture during the transition to whole-cell configuration, cells
with resting potentials of45mV or seal resistances of100
megaohms were omitted from analysis. The steady-state volt-
age responsewas plotted against the amount of current injected
to measure a voltage-current (V-I) relationship. Total input
resistance of the cell was determined from the slope of the lin-
ear portion of this relation, according to Ohm’s law, V  IR.
Input conductance was calculated as the inverse of resistance
(G  1/r  I/V). Evoked spikes were counted and plotted
against the amount of injected current.
Immunofluorescent Labeling—Live neuronswere immunola-
beled without fixation using a published protocol (11). A V5
epitope tag including a linker sequence followed by a His6 tag
already encoded in the pcDNA3.1 vector was added to the C ter-
minus ofGluCl and subunits (-CASKGNSADIQHSGGRSSL-
EGPRFEGKPIPNPLLGLDSTRTGHHHHHH) by mutation of
the stop codon (see above). The His6 tag was not utilized. Sur-
face receptors were labeled with primary mouse monoclonal
anti-V5 antibody (1:200; catalog no. R960-25, Invitrogen) fol-
lowed by a conjugated secondary Alexa Fluor 555 donkey anti-
mouse antibody (1:400; catalog no. A-31570, Invitrogen). Anti-
bodies were diluted into warm artificial cerebrospinal fluid and
applied sequentially, incubating each for 30 min at 37 °C/5%
CO2 with appropriate rinse steps. Live cultures were imaged
immediately after immunostaining.
Imaging—Living HEK293 cells and cultured neurons were
imaged at 37 °C in a stage-mounted culture dish incubator
(Warner Instruments). Transiently transfected HEK293 cells
were imaged by TIRF microscopy, which enabled visualization
of fluorescent receptors expressed in the plasma membrane
and nearby intracellular vesicles (within 200 nm of the cell-
coverslip interface). Prior to imaging, cell culture medium was
replacedwith phenol red-freeCO2-independent Leibovitz L-15
medium (catalog no. 21083-027, Invitrogen). TIRF images were
obtained using an inverted microscope (Olympus IX81) with a
100/1.45 numerical aperture Plan Apochromat oil objective.
A stepping motor (T-cube stepper motor, Thorlabs) was used
to control the position of the fiber optic and TIRF evanescent
field illumination. A 488-nm laser was used to excite mono-
meric YFP fluorescence. Images were acquired using
MetaMorph Premier software (Molecular Devices) at 16-bit
resolution over 512  512 pixels and captured using a back-
illuminated EMCCD camera (iXON DU-897) supported by
ANDOR iQ2 software (Andor Technology).
Transiently transfected hippocampal neuron cultures were
imaged using a laser-scanning confocal microscope (Nikon
Eclipse C1si) equipped with a 63/1.4 numerical aperture VC
Plan Apochromat oil objective. Monomeric YFP fluorescence
was acquiredwith 514-nm laser excitation. Alexa Fluor 555 and
pDsRED2 (catalog no. 632409, Clontech) fluorescence was
acquiredwith 561-nm laser excitation. Imageswere collected as
z-stacks at a step size of 1.0 m with 16-bit resolution over
512 512 pixels and a dwell time of 6.72 s.
For confocal image analysis, the two different fluorescent
signal intensities were correlated on a pixel-by-pixel basis using
the ColocalizationColormap ImageJ plug-in (AdamGorlewicz;
available at the ImageJ web site). This software is based on a
previously published algorithm (12). The correlation of a pair of
pixels was calculated by the normalized mean deviation prod-
uct (nMDP) as follows,
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nMDPx,y
	Ia Ia
	Ib Ib

	Iamax Ia
	Ibmax Ib

(Eq. 1)
where the intensity (I) for a given pixel in one image (a or b) is
normalized to the average intensity andmaximum intensity for
that image. The nMDP values for each pixel range from1 to 1
and are visualized on a color scale (see Figs. 7 and 8). Values0
are represented by cold colors for exclusion of one fluorophore,
and values0 are shown in hot colors, indicating colocalization
of both fluorophores. For the experimental conditions of the
current study, the average of all positive (colocalized) nMDP
values corresponds to total receptor surface expression,
whereas the average number of perfectly correlated pixels (i.e.
nMDP 1) indicates the relative amounts of each subunit.
Statistics—Pooled data are shown as means S.E. Box plots
represent the mean, median, 25th, and 75th percentiles. Statis-
tical significance (p 0.05) was determined by one-way analy-
sis of variance on ranks using multiple pairwise comparison.
RESULTS
Gain-of-function Gating Mutation Increases Receptor Sensi-
tivity to IVM—GluCl is a member of the Cys-loop superfamily
of ligand-gated ion channels in which five individual subunits
form homomeric or heteromeric receptor subtypes with vary-
ing functional properties. A number of studies on both cation-
selective (nicotinic acetylcholine and serotonin 5-HT3) and
anion-selective (GABA and glycine) Cys-loop receptors have
demonstrated that mutation of a highly conserved pore-lining
residue, leucine 9, to one of several other amino acids can dra-
matically increase agonist sensitivity through effects on chan-
nel gating (13–21). This gain-of-function effect is evident in the
dose-response relation, in which channel activation occurs
with lower concentrations of agonist.
To test GluCl receptors for increased IVM sensitivity, the
highly conserved leucine 9 residue in the M2 domain of the 
subunit was mutated to one of seven other residues: L9I, L9F,
L9V, L9A, L9G, L9S, or L9T. Heteromeric GluCl  wild-
type (WT-XFP) and leucine 9 mutant channels (also XFP-
tagged) were expressed in HEK293 cells and screened for
receptor activation using a fluorescence-based assay with a
membrane potential-sensitive dye. All mutants, except for
L9F, displayed reduced signals for IVM activation compared
withWT-XFP (Fig. 1A).Weak agonist-induced signalswere the
result of elevated base-line fluorescence (data not shown), sug-
gesting an increased level of background conductance, which
has been reported for some leucine 9mutations in other Cys-
loop receptors (13, 20, 22–25). The L9F mutant retained a
maximal response comparable with that of WT-XFP. Fitted
IVM activation parameters for the normalized mean signal
show a biphasic concentration-dependent relation for the L9F
mutant with an unambiguous increase in IVM sensitivity
throughout the unsaturated concentration range compared
with WT-XFP (Fig. 1B and Table 1). As a result, L9F was des-
ignated as the best candidate mutation for increasing the sen-
sitivity and preserving the amplitude of the ivermectin
response.
The membrane potential-sensitive dye assay unexpectedly
revealed thatHEK293 cells expressingGluCl homomerswere
indeed responsive to IVM (Fig. 1C), despite the failure of pre-
vious electrophysiological studies to detect IVM responses
from  homomers expressed in mammalian cell lines (1, 2).
GluCl  homomers containing the L9F mutation were also
responsive but did not show increased sensitivity to IVM (Table
1), implying that the gain-of-function effect of L9F on IVM
sensitivity requires co-assembly with the  subunit. GluCl 
homomers were not responsive to applications of IVM.
Mutation of a Putative ER RetentionMotif Enhances the High
Sensitivity IVM Response—In the cell, multimeric membrane
proteins are synthesized, matured, and assembled in the endo-
plasmic reticulum (ER) (26, 27). Proteins that are misfolded,
unassembled, or improperly assembled are retained in the ER
and ultimately targeted for ER-associated degradation (28, 29).
This mechanism ensures that only properly assembled recep-
tors are transported to the cell surface.
The amino acid sequence of a plasma membrane protein
often contains specific signalingmotifs to facilitate retention or
export of the protein from the ER. The best characterized ER
exit signals includeDXE (30, 31), LXX(L/M)E (32), and (I/L)XM
(33). These motifs exist on the cytosolic loops of a variety of
membrane-associated proteins, where they are recognized by
FIGURE 1.Channel gatingmutation L9F increases IVMsensitivity of heteromeric GluCl.A, concentration-response data for IVMactivation of heteromeric
GluCl WT-XFP and seven different leucine 9 mutant receptors measured with a fluorescent membrane potential-sensitive dye. Response magnitudes are
measured in relative fluorescence units (RFU). B, normalized IVM concentration-response relations for heteromeric GluCl WT-XFP and L9F mutant receptors.
The IVMconcentration-response relation for the L9Fmutantwas best fit by the sumof twoHill equations.C, normalized IVMconcentration-response relations
for WT-XFP and L9F GluCl  homomers. Fitted parameters for IVM concentration-response relations are given in Table 1. Error bars, S.E.
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the primary cargo selection protein (Sec24) of the COPII-
coated vesicles for transport from ER to Golgi. Well character-
ized ER retention signals include the classical C-terminal
motifs, KDEL and KKXX (34, 35), and the cytosolic arginine-
based signal, RXR (36). The RXR motif occurs in potassium
channels (36), G-protein-coupled receptors (37), voltage-de-
pendent Ca2 channels (38), ionotropic glutamate receptors
(39–41), and ionotropic Cys-loop receptors (42–44). Proteins
containing the RXR motif are inferred to be retained in the ER
(or maintained by COPI retrieval) until the retention signal is
masked by multimeric assembly with other receptor subunits
(45–47).
Fig. 2A notes putative ER signaling motifs in the amino acid
sequences of GluCl  and , in the large M3-M4 intracellular
loop of each subunit. The  subunit contains a single putative
ER export motif (LNLLE) immediately following the fluores-
cent fusion protein (XFP tags were inserted at restriction sites
(3)). The  subunit contains two putative ER export motifs
(LEMandDAE) and two putative ER retentionmotifs (RSR and
RRR). The presence of putative retention motifs in  and their
absence in  is consistent with the functional expression
observed for these subunits in mammalian systems. For exam-
ple, in the non-mammalian Xenopus laevis oocyte expression
system, both  and  subunits form functional homomeric
channels, of which  homomers are activated by IVM and 
homomers are activated by glutamate (note thatheteromers
can be activated by either glutamate or IVM) (48). In HEK293
cells, however,  homomer activation can be observed, but no
agonist-induced response has successfully been detected for 
homomers using either electrophysiology or fluorescence-
based membrane potential assays (data not shown). This sug-
gests that one or both of the retention motifs in the  subunit
may prevent/limit its export to the plasma membrane in the
absence of  subunits. Removal of ER retention signals could
potentially allow for more uniform receptor expression and
consistent neuronal silencing. To investigate this possibility,
the putative ER retentionmotifs of the  subunit were mutated
to alanine residues: GluCl -YFP R318A/S319A/R320A for an
“RSR_AAA” mutant and GluCl -YFP R329A/R330A/R331A
for an “RRR_AAA” mutant.
Themutant  subunits were co-expressed with  to produce
heteromeric receptors inHEK293 cells and tested for IVMacti-
vation using the fluorescent membrane potential assay. The
RSR_AAA and RRR_AAAmutant receptors as well as a double
mutant receptor, RSR_AAA/RRR_AAA, produced IVM con-
centration-response relations similar to that of the WT-XFP
receptor (Fig. 2B and Table 1). However, the RSR_AAAmutant
displayed a distinct biphasic relation, suggesting the presence
of an additional receptor population with high IVM sensitivity,
presumably one with greater  subunit incorporation. The
addition of the L9F gain-of-function mutation to the
RSR_AAAmutant receptor further enhanced the high sensitiv-
ity component of the IVM concentration-response relation. A
comparison of peak amplitudes in response to 10 nM IVM indi-
cated that the L9F RSR_AAA mutant receptor significantly
increased receptor activation using lower concentrations of
IVM (Fig. 2C). No IVM response was observed when mutant 
subunits were expressed the in absence of the  subunit, imply-
ing that the removal of these putative retention motifs was not
sufficient for surface expression of functional  homomers.
Addition of the Glutamate-insensitive Mutation Eliminates
High IVM Sensitivity—To use this L9F  RSR_AAA hyper-
IVM-sensitive GluCl mutant receptor for pharmacogenetic
silencing, sensitivity to the endogenous neurotransmitter glu-
tamate had to be eliminated. Astonishingly, reintroduction of
the glutamate binding site mutation Y182F in the  subunit
abolished the high sensitivity component of the biphasic IVM
concentration-response relation (Fig. 3A). The addition of the
Y182F mutation to the singly mutated L9F and RSR_AAA
mutant receptors showed a similar effect (Fig. 3, B and C).
Despite the loss of high IVM sensitivity, the Y182F mutation
did suppress the glutamate sensitivity of the receptors (data not
shown).
A Mutation That Prevents XFP Dimerization Restores High
IVM Sensitivity—Fluorescent proteins tend to dimerize at high
concentrations (49), but dimerization can also occur when
XFPs are spatially restricted, such as when they are fused to
membrane proteins (50). We suspected that XFP dimerization
might interfere with IVM sensitivity because heteromericWT-
XFP receptors with YFP and CFP tags on either or both sub-
TABLE 1
Fitted parameters for IVM concentration-response relations of WT andmutant GluCl receptors
Parameters correspond to IVM concentration-response relations in Figs. 2–4. The EC50 and Hill coefficient values represent the mean  S.E. for the number of
measurements (n) obtained. The relative fraction of the high sensitivity component (1st comp) for the biphasic relations is included.
GluCl channel 1st comp EC50 Hill EC50 Hill n
nM nM
(WT) (WT) 107.14 10.94 1.04 0.09 12
-YFP -YFP 302.08 54.34 1.44 0.27 12
-YFP L9F -YFP 0.61 7.27 2.85 1.14 0.24 185.35 50.16 1.99 0.82 6
-YFP homomer 406.88 21.08 2.47 0.24 6
-YFP L9F homomer 472.67 44.23 1.64 0.19 6
-YFP -YFP RSR_AAA 0.35 8.55 3.16 2.50 1.67 163.15 38.31 2.04 0.84 6
-YFP -YFP RRR_AAA 111.88 9.98 1.44 0.16 6
-YFP -YFP RSR_AAA/RRR_AAA 233.06 17.71 1.44 0.13 6
-YFP L9F -YFP RSR_AAA 0.53 3.91 1.69 1.64 0.69 95.28 30.91 2.24 1.27 12
-YFP -YFP Y182F 380.41 105.68 1.14 0.24 6
-YFP L9F -YFP Y182F 159.81 20.71 1.07 0.12 6
-YFP -YFP Y182F RSR_AAA 365.49 48.35 1.35 0.17 6
-YFP L9F -YFP Y182F RSR_AAA 45.08 5.37 1.21 0.14 6
-mYFP -mYFP 0.29 3.58 3.66 1.16 0.80 170.46 32.61 2.16 0.79 6
-mYFP L9F -mYFP 0.49 1.35 0.47 1.36 0.85 185.58 62.75 2.24 1.65 6
-mYFP L9F -mYFP Y182F RSR_AAA 0.63 3.35 1.36 1.04 0.27 196.26 49.81 2.50 1.64 6
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units all displayed IVM concentration-response relations that
were right-shifted relative to the untagged WT receptor (Fig.
4A). The full data set for XFP-tagged and untagged subunits
revealed that rightward shifts occurred only when the fluores-
cent protein was present in the  subunit (Fig. 4B). In further
observations, the IVM concentration-response relation of the
-XFP homomer was also right-shifted relative to untagged 
homomers (data not shown), again suggesting a loss of IVM
sensitivity mediated by the fluorescent protein insertion.
Strictly monomeric XFPs (mXFPs) can be obtained by
mutating the Ala-206 residue to Lys, a long, positively charged
side chain that disrupts the hydrophobic dimer interface (51).
Incorporating this mutation into the fluorescently tagged
GluCl constructs prevented the rightward shift and even added
a high sensitivity component to the IVM concentration-re-
sponse relation ofWT-mXFP (Fig. 4C). IncludingmXFPmuta-
tions in the heteromeric L9F receptor produced a biphasic
concentration-response relation more pronounced than any
other previously obtained (Fig. 4D). More importantly, intro-
ducingmYFP into the initially favoredL9FRSR_AAArecep-
tor restored the high IVM sensitivity component that was lost
upon the addition of the glutamate-insensitive Y182F muta-
tion. This GluCl -mXFP L9F  -mXFP Y182F RSR_AAA
mutant receptor was more sensitive to IVM than GluClv1.0 by
2 orders of magnitude (Fig. 4E and Table 1) while preserving
insensitivity to physiologically relevant concentrations of glu-
tamate (1 mM; Fig. 4, F–H) (52–54).
Biphasic Concentration-Response Relation Reflects Mixed
Receptor Subunit Stoichiometries—In pentameric Cys-loop
receptors, multicomponent concentration-response relations
typically result when several subunit stoichiometries with dif-
fering agonist sensitivities are present in the receptor popula-
tion (55–57). Variation in subunit stoichiometry may account
for the biphasic IVM concentration-response relations
observed for certain mutant GluCl subunit combinations. The
 subunit L9F mutation adds a high sensitivity component to
FIGURE 2.Mutation of putative ER retentionmotif RSR also increases IVM sensitivity of heteromeric GluCl. A, putative ER signalingmotifs in GluCl and
 subunits. Amino acid sequences of the intracellularM3-M4 loop and flanking regions of GluCl and. The last amino acid of each sequence is the C-terminal
residue. Transmembrane-spanning helices (M3 andM4) are underlined. The fluorescent protein (XFP) insertion point is denoted by dashed lines. The subunit
contains a single putative ER export motif (LXX(L/M)E). The  subunit contains two possible ER export motifs ((I/L)XMand DXE) and two potential ER retention
motifs (RXR). B, normalized IVM concentration-response relations for heteromeric receptors containing RSR_AAA, RRR_AAA, and the double RSR_AAA/
RRR_AAA mutations compared with WT-XFP. The RSR_AAA mutant produces a biphasic concentration-response relation. The addition of an L9F mutation
further enhances thehigh sensitivity component.C, the L9FRSR_AAAmutant receptor significantly increases thepeak amplitudeof the10nM IVM response
relative to WT-XFP. IVM activation was measured using a fluorescent membrane potential assay. Fitted parameters for IVM concentration-response relations
are given in Table 1. Error bars, S.E.
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the IVM concentration-response relation only when co-ex-
pressed with the  subunit. Mutation of an ER retention
sequence in the  subunit, which presumably increases the
probability of  incorporation into the receptor, has a similar
effect. Thus, the high IVM sensitivity component probably
manifests from a shift in the ratio of / subunits in the assem-
bled pentamer to include more . To test this hypothesis, dif-
ferent ratios of  and  subunit DNA (1:1, 4:1, and 1:4) were
transfected into HEK293 cells, and the IVM concentration-re-
sponse relations were again measured using the fluorescent
membrane potential assay. Consistent with our previous
results, a 1:1 ratio produced a biphasic concentration-response
relation. Biasing the ratio in favor of (4:1) produced a decrease
in IVM sensitivity, whereas biasing the ratio in favor of  (1:4),
produced no further increase in IVM sensitivity (Fig. 5). There-
fore, incorporation of the  subunit confers increased receptor
sensitivity to IVM, but transfection of equal amounts of and
subunit DNA appears to be optimal.
The fluorescent protein tags permit direct visualization and
localization of GluCl subunits expressed in a cell. Images of
HEK293 cells obtained by TIRF microscopy show that GluCl
 heteromers and  homomers are expressed at the plasma
membrane, but  homomers are not (Fig. 6, A and B). Specifi-
cally, the -mYFP subunit shows plasma membrane fluores-
cencewhen transfected alone or cotransfectedwith untagged.
The -mYFP subunit, on the other hand, shows plasma mem-
brane fluorescence only when cotransfected with untagged .
Transfection of the -mYFP subunit alone displays complete
ER retention, as evidenced by the reticulated pattern of fluores-
cence and the lack of fluorescent filopodia at the periphery.
GluCl -mYFP subunits bearing the RSR_AAA, RRR_AAA, or
the double RSR_AAA/RSR_AAA mutations display fluores-
cence patterns similar to the -mYFP homomer (Fig. 6C).
Thus, disruption of the putative ER retention motifs in the 
subunit is not sufficient to allow plasma membrane expression
of  homomers.
RSR Mutation Increases  Subunit Expression at the Plasma
Membrane and the ER—The results above suggest that the ER
retentionmutation RSR_AAA enhances incorporation of the 
subunit into heteropentameric GluCl receptors expressed on
the cell surface. Although HEK293 cells were convenient for
screening receptor function, primary neuronal cultures provide
a more appropriate environment for investigating patterns of
subunit expression. Preliminary confocal images of fluores-
cently tagged subunits transfected into embryonic rat hip-
pocampal neurons displayed a deficient neuronal expression
pattern for GluCl homomers withminimal extension into the
processes and comparatively few fluorescent neurons per imag-
ing dish. GluCl  homomers and  heteromers, on the other
hand, exhibit extensive fluorescent projections with no gross
discernible differences (data not shown). Distinguishing
between receptors retained in the ER and those expressed at the
plasma membrane required colocalization markers.
Receptors expressed at the plasma membrane were targeted
by live cell immunofluorescent surface staining. A V5 epitope
tag was added to the extracellular C terminus of both  and 
and subunits, which were then assayed for channel function in
HEK293 cells to verify that pentameric assembly was not dis-
rupted (data not shown). Cultured rat hippocampal neurons
were then transfectedwith fluorescently tagged and/or sub-
units with one of the subunits containing the V5 epitope (e.g.
-mYFPV5  -mYFP). V5-tagged subunits expressed at the
cell surface were detected by immunostaining with an anti-V5
primary antibody followed by a fluorescent Alexa Fluor 555-
conjugated secondary antibody. Immediately after staining, the
entire neuron was scanned for red and yellow fluorescence
using confocalmicroscopy. Yellow fluorescence contributed by
both subunits (mYFP) reflected total protein expression and
was used to locate transfected neurons within the dish. Red
fluorescence from live cell immunostaining (Alexa Fluor 555)
emitted only from labeled subunits expressed at the cell surface.
The extent of red and yellow fluorescent colocalization, there-
fore, served as a relative measure of surface expression, mini-
mizing the effects of nonspecific antibody staining in our anal-
ysis. The fluorescence intensity correlation for each pixel was
calculated by the nMDPand visualized on a color scale (Fig. 7A).
Colocalization is evidenced by all positive nMDP values (0 
x  1; shown in hot colors) and occurs only for receptors
FIGURE 3. Reintroduction of the glutamate-insensitive mutation eliminates mutant-induced increases in IVM sensitivity. A, normalized IVM concen-
tration-response relations show reintroduction of the Y182F mutation eliminates the high sensitivity component of the biphasic concentration dependence
for theL9FRSR_AAAmutant receptor (fromFig. 2).BandC, theY182Fmutation similarly affected theconcentration-response relationsof the individual L9F
and RSR_AAA mutant receptors. IVM activation was measured using a fluorescent membrane potential assay. Fitted parameters for IVM concentration-
response relations are given in Table 1. Error bars, S.E.
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expressed at the surface.Hence, greater nMDPvalues indicate a
greater amount of GluCl expression at the plasma membrane.
The overall average of positive nMDP values provides a rel-
ative representation of total surface expression levels of recep-
tor (note that the sum of all positive nMDP values is distorted
by the size and number of cells imaged). Heteromeric WT
receptors show the same level of total surface expression
regardless of whether the V5 tag was on the  or  subunit (Fig.
7B). Homomeric receptors (transfected 1:1 with V5-tagged and
untagged subunits for comparison with heteromers) corrobo-
rated the previous HEK293 cell observations that  homomers
are expressed at the plasma membrane of neurons at levels
comparable with  heteromers but that  homomers are not.
Heteromeric receptors bearing the RSR_AAA retention muta-
tion in the  subunit showed the same total surface expression
levels asWT heteromers and  homomers, whereas those with
FIGURE 4. Dimerization of the fluorescent protein (XFP) tags affects IVM sensitivity. A, IVM concentration-response relations for heteromeric receptors
with either YFP or CFP tags on both subunits are right-shifted compared with the untagged WT receptor. B, co-expression of tagged and untagged subunits
reveals right-shifted relationsparticularlywhen the fluorescent protein is present on the subunit. Fittedparameters for IVMconcentration-response relations
are given in the corresponding table. C, introduction of an mYFPmutation rectifies the rightward shift and adds a high sensitivity component. D, monomeric
YFP also enhances the high IVM sensitivity component of the already biphasic L9F concentration-response relation. E, finally, mYFP restores the high IVM
sensitivity component lost upon the addition of the Y182Fmutation to the L9F RSR_AAA receptor (from Fig. 3A). This newly engineered receptor (-mXFP
L9F -mXFP Y182F RSR_AAA) is100-fold more sensitive to IVM than GluClv1.0. Fitted parameters for IVM concentration-response relations are given in
Table 1. F, glutamate concentration-response relations forWT, GluClv1.0, and the revised receptorwith the fluorescentmembranepotential dye.G, the revised
receptor retains insensitivity to physiologically relevant concentrations of glutamate (1mM).H, sample fluorescent responses to 1mMglutamate. Error bars, S.E.
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the RRR_AAA and double RSR_AAA/RRR_AAAmutations in
the  subunit resulted in lower surface expression levels.
Examining the number of maximally correlated pixels
(nMDP 1) within an image more directly represents surface
expression levels of  versus  subunits. On average, the het-
eromeric WT, RRR_AAA, and RSR_AAA/RRR_AAA mutant
receptors showed a greater number of maximally correlated
pixels when the V5 tag was on the  subunit than on the 
subunit, suggesting a greater number of  subunits present in
the assembled pentamer (Fig. 7C). Heteromeric RSR_AAA
mutant receptors, on the other hand, showed that maximal
colocalization occurred more often for V5-tagged  than
V5-tagged , consistent with a shift in subunit stoichiometry.
Altogether, the immunofluorescent results suggest that muta-
tion of the putative RSR retention motif in the  subunit does
not increase the total number of receptors trafficked to the
plasma membrane but does increase the number of  subunits
incorporated into assembled surface receptors.
To determine the relative amounts of WT and mutated 
subunits remaining in the ER, colocalization analysis was per-
FIGURE 5.Biasing the subunit transfection ratio in favor of suppresses the high sensitivity component of the biphasic IVM concentration-response
relations. Different ratios of  and  plasmid DNA (1:1, 4:1, and 1:4) were transfected into HEK293 cells. A 1:1 ratio (black symbols, solid line) produced the
expected two-component concentration-dependent relationship for L9F (A) and RSR_AAA (B) mutant receptors. Biasing in favor of the  subunit (1:4; open
symbols, dashed line) does not further enhance IVM sensitivity. In contrast, biasing in favor of  (4:1; gray symbols, solid line) reduces IVM sensitivity. Fitted
parameters for IVM concentration-response relations are given in the corresponding table. Error bars, S.E.
FIGURE 6. Visualization of GluCl subunit expression in HEK293 cells. A, TIRF images show fluorescent  and  subunits are expressed at the plasma
membrane as heteromers. GluCl  homomers are also expressed at the plasma membrane. B, a reticulate pattern of fluorescence and the lack of hairlike
filopodia at the periphery suggest thathomomers are exclusively retained in the ER.C, mutation of the putative ER retentionmotifs in the subunit does not
alter this pattern of fluorescence and therefore does not enable plasma membrane expression of  homomers.
GluClv2.0, an Improved Neuronal Silencer
JULY 19, 2013•VOLUME 288•NUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 21037
 at CALIFORNIA INSTITUTE OF TECHNOLOGY on September 5, 2013http://www.jbc.org/Downloaded from 
formed on neurons cotransfected with non-fluorescent  sub-
units and the various mYFP-tagged  subunits together with
the fluorescent ER marker dsRED (Fig. 8A). Once again, the
RSR_AAA mutant differed significantly from WT and the
RRR_AAA and RSR_AAA/RRR_AAAmutants, but rather than
showing reduced ER localization, as would be presumed by
relief of retention, the RSR_AAA mutant showed greater
expression levels in the ER compared with the other  subunits
(Fig. 8B). Because newly synthesized, improperly folded, or
unassembledCys-loop subunits remaining in the ER are known
to be rapidly degraded (58–62), mutation of an ER retention
motif could conceivably influence subunit degradation. These
results may suggest that the RSR_AAAmutant  subunit is not
being degraded as quickly, leaving more available for hetero-
meric assembly with  subunits.
An Improved Neuronal Silencing Tool—Rational mutation
has led to a newly engineered GluCl receptor with increased
sensitivity to IVM and improved expression of the  subunit.
To determine whether this GluCl -mXFP L9F  -mXFP
Y182F RSR_AAA receptor is indeed an improved neuronal
silencing tool over GluClv1.0, IVM-induced conductance and
spike inhibition were measured from dissociated hippocampal
neurons expressing these receptors (identified by fluorescence
microscopy). Neurons were incubated with 0, 1, or 20 nM IVM
for 15 min, rinsed with IVM-free saline, and then recorded in
whole-cell current clamp mode for V-I relations using square
current injection steps of100 to 250 pA in 25-pA increments
(Fig. 9A). The newly engineered receptor showed a significant
increase in conductance (measured from the linear portion of
the V-I relation; Fig. 9C) and a reduction in the mean evoked
spike count (Fig. 9B) for both 1 and 20 nM IVM compared with
GluClv1.0. Not only was spike suppression enhanced, the vari-
ability in spike suppression was also significantly reduced (Fig.
9D). Neither the presence of IVMnor receptor expression itself
affected the resting membrane potential, confirming the integ-
rity of induced spike inhibition (Fig. 9E). Thus, neuronal silenc-
ing achieved through IVM activation of the newly modified
GluCl is indeed more sensitive and less variable than for
GluClv1.0.
DISCUSSION
Previous in vitro and in vivo studies report that co-expression
of both  and  subunits is required for GluCl-mediated neu-
ronal silencing (1, 2). Variability in GluCl subunit expression
(particularly that of the  subunit) appeared to be responsible
for whether or not an individual neuron was inhibited by
IVM. Our results show that functional, IVM-sensitive 
homomers are actually expressed at the plasma membrane,
but inclusion of the  subunit increases GluCl sensitivity to
IVM. Therefore, variation in the proportion of heteromeric
and homomeric receptors within individual neurons may
account for the previously reported variation in IVM-in-
duced spike suppression. We improved on the previous
GluClv1.0 construct, introducing three new amino acid
modifications. These modifications still do not provide a
homogeneous receptor population, but, nevertheless, they
generate a receptor population that is significantly more sen-
sitive to IVM and that exhibits reduced variability in spike
suppression. Therefore, this revised GluCl receptor, dubbed
“GluClv2.0,” should allow lower doses of IVM to be admin-
istered for in vivo silencing, alleviating concerns of side
effects and suboptimal inhibition.
FIGURE 7. The RSR_AAA mutation increases plasma membrane expres-
sion of the  subunit but not the total number of receptors. A, confocal
image example of colocalized Alexa Fluor 555 immunofluorescent surface
staining and intrinsic mYFP fluorescence of GluCl -mYFPV5  -mYFP
viewed with the colocalization color scale. An nMDP correlation value is cal-
culated for each pixel based on fluorescence intensity.Hot colors (nMDP 0)
denote colocalization and hence surface expression. B, the average of all pos-
itive nMDP values for a given receptor is representative of its total surface
expression. GluClhomomers are expressed at theplasmamembrane, and
homomers are not. For heteromers, the same level surface expression was
obtained regardless of whether the V5 tag was on the  or  subunit. Recep-
tors bearing putative ER retention motif mutations do not increase total
receptor surface expression compared with WT. C, the average number of
pixels with nMDP values of unity indicates that more maximally correlated
pixels occur with V5-tagged  than with V5-tagged  when WT, RRR_AAA,
and RSR_AAA/RRR_AAA receptors are expressed as heteromers. In contrast,
the RSR_AAA mutant receptor shows more maximal colocalization with
V5-tagged  than with V5-tagged , suggesting a shift in surface receptor
subunit stoichiometry. Error bars, S.E.
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Mechanisms of the Optimized Receptor—Concentration-re-
sponse relations of GluCl  homomers and  heteromers
bearing an L9Fmutation in the  subunit show that co-assem-
bly with the  subunit significantly increases IVM sensitivity.
The effects of biasing the stoichiometric ratio of transfected 
and  subunits not only support this conclusion, they suggest
that the L9F mutation prefers or possibly promotes  subunit
incorporation because biasing for  subunit expression with a
4:1 / subunit ratio still yields a biphasic IVM concentration-
response relation for this mutant. Even the low sensitivity com-
ponent of this relation is more sensitive (EC50 150 nM) than
that of L9F homomers (EC50  450 nM). Cys-loop receptor
assembly (as described by one theory) involves an initial subunit
dimerization step, followed by the dimerization of dimers and
subsequent inclusion of a fifth subunit to form the final penta-
mer (63). The L9Fmutationmay either promote-dimeriza-
tion or hinder - dimerization, favoring the formation of a
predominantly heteromeric  receptor population that
includes more  subunits per assembled receptor.
According to conjecture, the arginine-based ER retention
motif of the  subunit requires masking by co-assembly with
the  subunit to exit the ER. This mechanism may explain the
absence of  homomers at the plasma membrane. Our data
show that removal of the retentionmotif (RSR_AAA) increases
the amount of  exported to the plasmamembrane in the pres-
ence of . However, the RSR_AAA mutation also elevates 
subunit levels in the ER, indicating that it does not simply
enhance  subunit surface expression by reducing ER reten-
tion. Moreover, simply mutating the ER retention motif is
not sufficient to allow surface expression of  homomers,
suggesting that an additional unknown quality control
mechanism is involved in  subunit retention. One possible
explanation is that the RSR_AAA mutation impedes ER-as-
sociated degradation of the  subunit. It could do so either
directly, prolonging its availability for - dimerization, or
indirectly, by facilitating stable - dimer formation. A sim-
ilar stabilizing effect within the ER appears to underlie nic-
otine-induced up-regulation of 42 nicotinic acetylcholine
receptors to the plasma membrane (44). We do not know the
extent to which the availability of  subunits in the ER
impacts the propensity of  homomer formation. Limiting 
subunit degradation may keep  homomer expression to a
minimum.
The reason why reintroduction of the glutamate-insensitive
mutation eliminated increased IVM sensitivity is less clear. The
Y182F binding site mutation may reduce protein expression/
stability of the  subunit or somehow inhibit - dimer forma-
tion. We cannot exclude the possibility that this mutation
affects IVMactivation ofGluCl by interferingwith the coupling
between agonist binding and gating (64). However, restoration
of the high sensitivity component of the IVM concentration-
response relation by introducing the mYFP mutation suggests
that it is more likely to be a consequence of altered subunit
stoichiometry. The glutamate binding site is positioned at sub-
unit interfaceswhere structuralmodifications could potentially
disrupt heteromeric assembly. In this instance, the Y182F
mutation would be preventing efficient pentameric incorpora-
tion of the subunit, counteracting the benefits of the L9F and
RSR_AAA mutations.
Application of GluClv2.0—Since the initial proof-of-concept
study, GluClv1.0 has been used in conjunction with channel-
rhodopsin-2-mediated activation to define an inhibitorymicro-
circuit within the amygdala involved in mouse fear condition-
ing (65) and to identify a hypothalamic locus responsible for
male mouse aggression and its close neuroanatomical relation-
ship to mating circuits (66). In the former study, an intersec-
tional approach was used to restrict GluCl expression to
PKC--containing GABAergic neurons in the central
amygdala. Selective localization was achieved by targeted
transgenic expression of GluCl -CFP in all PKC- neu-
rons, followed by stereotaxic injection of an adeno-associ-
ated vector encoding GluCl -YFP Y182F. Although GluCl/
IVM-mediated silencing of PKC- neurons yielded a
significant enhancement of conditional freezing, the behav-
ioral result was again confounded by a bimodal phenotype.
Histological data revealed considerable variation in expres-
sion of the virally injected  subunit, reminiscent of the stri-
atal proof-of-concept study. Interestingly, control animals
transgenically expressing  alone were not affected by treat-
ment with 10 mg/kg IVM, despite our present results indi-
cating that  homomers are indeed expressed at the plasma
membrane. Most likely,  homomer activation elicits insuf-
ficient Cl current to achieve neuronal silencing.
GluClv2.0 maintains the requirement of both  and  sub-
units for silencing. The pharmacokinetic properties of the
silencing tool have not been altered. Another variant of IVM-
FIGURE8.TheRSR_AAAmutationalso increases subunit expression in theER.A, confocal imageofGluCl(WT)-mYFP and the fluorescent ERmarker
dsRED viewed with the colocalization color scale. B, the average of all positive nMDP values represents the extent of  subunit localization in the ER. The
RSR_AAAmutant subunit shows increased presence in the ER. Error bars, S.E.
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induced silencing has been achieved by increasing the sensitiv-
ity of a mammalian homomeric glycine receptor (67), although
this tool remains to be verified in vivo. In addition, an alterna-
tive Cys-loop orthogonal pharmacological silencing tool (based
on chimeric nicotinic acetylcholine-glycine receptors of mam-
malian origins) capable of activating and inactivating on shorter
time scales has recently been constructed (68). However, the
cognate synthetic nicotinic agonist has demonstrated weak to
moderate binding of other endogenous nicotinic acetylcho-
line receptors, and the absence of potential co-assembly of
chimeric subunits with endogenous nicotinic acetylcholine
receptors has not yet been verified. Even faster time-resolved
neuronal silencing can be achieved using optogenetic tech-
niques (69, 70), but this method is invasive and is not suitable
for silencing large anatomical regions or diffuse signaling
networks. The duration of light-induced manipulation is
further limited by heat generation, which may alter neuronal
activity or damage cell health (71). Thus, orthogonal phar-
FIGURE 9.An optimized neuronal silencing tool. Action potential firing in response to depolarizing current pulses (100 to 250 pA, 25-pA increments) was
obtained fromculturedhippocampal neurons inwhole-cell current clampmode following a 15-minpreincubationwith 0, 1, or 20 nM IVM.A, linear rangeof the
V-I relations from neuronal cultures transfected with the revised construct (-mYFP L9F -mYFP Y182F RSR_AAA) was compared with those of GluClv1.0
(-YFP-YFP Y182F) and non-transfected neurons. The revised receptor exhibits lower input resistance (as indicated by the slope) at 1 and 20 nM IVM. B, the
revised receptor also reducedmeanevoked spike counts at 1 and20nM IVM. Insets, voltage response to current injections for individual neurons expressing the
original (top) and revised (bottom) receptors. C, the revised receptor induced a significant increase in conductance for both 1 and 20 nM IVM compared with
GluClv1.0 (*, p  0.01; **, p  0.001). D, variability in evoked spike suppression, noted by the S.D. (error bars) of the spike count along the abscissa, is also
significantly reduced with the revised receptor. E, neither construct expression nor the presence of IVM alone significantly altered the resting membrane
potential (Vmrest).
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macogenetic silencing using IVM activation of Cl-permea-
ble pentameric Cys-loop receptors remains a viable option
for long term neuronal inhibition (such as that required in
learning paradigms) and for assessing modulatory as
opposed to regulatory roles in neuronal circuitry.
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